Telemedicine Evaluation by Bashshur, Rashid L. et al.
296
TELEMEDICINE AND e-HEALTH
Volume 11, Number 3, 2005
© Mary Ann Liebert, Inc.
Telemedicine Evaluation
RASHID BASHSHUR, Ph.D., GARY SHANNON, Ph.D., and HASAN SAPCI, M.D.
ABSTRACT
This paper examines the context and status of evaluation research in telemedicine, and it pro-
poses a two-pronged strategy for addressing the critical policy and programmatic concerns in
this field. It explains the evolution of evaluation research in the United States, and it describes
a comprehensive typology and requirements for valid evaluation. Major impediments for de-
finitive evaluation are discussed, together with a summary of major trends in empirical stud-
ies. Two concurrent strategies are proposed for producing definitive findings and for assess-
ing the available empirical evidence. These consist of large-scale experimental studies and
theoretical and empirical triangulation for assessing the available empirical evidence.
The University of Michigan Health System, Ann Arbor, Michigan.
INTRODUCTION
THE INITIAL IMPETUS behind the developmentof telemedicine was its intuitive appeal as
an effective substitute for in-person medical
care and as an efficient tool in developing in-
tegrated systems of care. This appeal has been
supported by substantial experiential data in
various settings and clinical applications and,
more importantly, by a growing body of em-
pirical knowledge that, though mostly positive,
has yet to reach the level of conclusive and de-
finitive evidence needed for universal accep-
tance. At this stage in the evolution of telemed-
icine evaluation, it is possible to reach equally
justifiable yet differing conclusions as to the
significance and even the justification of eval-
uation.
On the one hand, one can claim that the ul-
timate adoption and diffusion of telemedicine
as an integral component of the medical care
system will depend on the hard evidence pro-
duced by rigorous scientific studies that eval-
uate its benefits and costs. From another point
of view, one can also claim legitimately that at-
tempts to evaluate telemedicine as a well-de-
fined and discrete modality of care are, in the
end, futile due to the fact that it is difficult, if
not impossible, to differentiate it from related
concepts. Moreover, the underlying technology
of telemedicine has developed a life of its own,
which continues to evolve on a fast pace.
Telemedicine applications also continue to pro-
liferate and now encompass all clinical areas in
addition to public health and medical and
health education. Therefore, it is futile to de-
fine a specific technology/human “fix,” and
call it telemedicine.
Indeed, since the field (including technology
and applications) is in constant flux, the most
appropriate evaluation should be aimed at in-
vestigating the benefits and costs of alternative
modalities and various dynamic combinations
and configurations of technology, human re-
sources, and health applications.
We chose to combine elements of both argu-
ments in this paper to move our thinking for-
ward on telemedicine evaluation as well as the
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field of telemedicine. At the same time, we ac-
knowledge the need to be creative and flexible
in evaluating this field to meet the require-
ments of various stakeholders, including poli-
cymakers, program developers, providers, and
clients. But, in the end, the goal of evaluation
should be to produce objective and credible ev-
idence regarding the merits and problems of
this field.
In this paper, we discuss basic issues and re-
quirements for the scientific evaluation of
telemedicine; review the status of evaluation
research in telemedicine from both method-
ological and substantive perspectives; and pro-
pose appropriate strategies and methodologies
that can be used in future evaluation studies
and in interpreting the available empirical ev-
idence. More specifically, we describe in gen-
eral terms the origin and goals of program eval-
uation research, the objectives of health-care
evaluation, a basic typology of evaluation
methods, the status of evaluation research in
telemedicine, and how we may interpret the
empirical evidence produced to date. As a de-
tailed illustration of how we can use the avail-
able evidence, we provide a theoretical model/
scheme for evaluating the impact of telemedi-
cine on access to care. This illustration is lim-
ited to telemedicine’s effects on access as other
presentations in this issue focus on outcomes
and cost.
BASIC ISSUES IN EVALUATION
The evaluation of health-care programs com-
bines scientific requirements and political real-
ities, which are often incompatible. Scientific
requirements pertain to the need for robust re-
search designs, reliable and valid measure-
ment, as well as rigorous methods for data col-
lection and data analysis. Political realities stem
from the priorities of public policy and fund-
ing agencies and the process of allocating re-
search funds.
Health-care evaluation may focus on a spe-
cific intervention or device or it may encom-
pass an entire health program or initiative.
When encompassing a program, evaluation
rests on the reasonable premise that allocating
public resources for large-scale health pro-
grams ideally is based on their expected costs
and benefits. Indeed, prudent policy must be
informed by factual information—where such
evidence exists—on costs and benefits of alter-
native programs and initiatives aimed at
achieving the same goals.
The evaluation of specific medical interven-
tions or medical devices, although based on a
similar set of assumptions as those for pro-
grams, has a more limited focus. Specifically,
the safety and effectiveness of new medical in-
terventions and devices must be demonstrated
before they can be approved for regular profes-
sional or consumer use. However, both concep-
tually and factually, telemedicine/telehealth/
ehealth combines elements of both health pro-
grams and related medical or health interven-
tions. Individual researchers, however, are at
liberty to (and frequently do) focus on either
programs or interventions or, less frequently,
on some combination of the two. In any case,
there currently is near-universal consensus that
public policy on investment in telemedicine/
telehealth/ehealth programs should be based on
scientific evidence of their benefits and costs,
as compared with alternatives. Hence, it is time
for the telemedicine community to reach an in-
formed consensus on an optimal methodology
to collect empirical evidence and interpret find-
ings in an objective and credible manner.
The discussion here focuses on the broader
problem of program evaluation rather than the
assessment of safety and effectiveness of spe-
cific medical or health interventions or devices.
(The latter problem is addressed briefly later.)
The issues of interest here include the origin
and goals of program evaluation in general, a
typology of evaluation objectives (or classifica-
tion of what is evaluated), evaluation methods
(or approaches), and the inherent methodolog-
ical and logistical difficulties in evaluating
telemedicine programs.
ORIGIN AND GOALS OF 
PROGRAM EVALUATION
The genesis of program evaluation research
and the involvement of social scientists in pub-
lic policy can be traced back to the 1930s when
President Franklin Roosevelt’s New Deal poli-
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cies established a number of large-scale social
welfare and public works programs aimed at
ending the Great Depression, creating social
equity, and invigorating the economy. Indeed,
the development of the welfare-oriented state
in the 1930s in the United States introduced so-
cial science involvement into public policy.
Some of the best empirical social research dur-
ing that decade was made possible by the
Works Progress Administration and the Na-
tional Youth Administration, which provided
funding for research assistants and unem-
ployed academics. Nonetheless, as a method of
inquiry, evaluation research did not introduce
any new or different research designs or ana-
lytic techniques. Hence, it is fair to character-
ize evaluation research as lacking a unique or
distinctive methodology. In fact, evaluators use
any or all of standard methodologies, includ-
ing clinical trials, sample surveys, and even the
dreaded focus group, which ignores nearly all
requirements for rigorous scientific research.
Most of the early work on the evaluation of
the New Deal was done by the Roosevelt Brain
Trust, consisting only of economists—no sociol-
ogists, psychologists, or anthropologists. Some
30 years later, the Great Society programs of
the 1960s represented an expansion of the New
Deal, reflecting the political climate of the time.
These programs were aimed at reducing, if not
eliminating, the significant economic, social,
educational, and health disparities in this coun-
try. In retrospect, the War on Poverty of the
1960s was established without any empirical
assessment of New Deal programs, or any
other federally sponsored social or public work
program for that matter. Indeed, we know lit-
tle, if anything, about the actual impact of spe-
cific New Deal programs in relation to their
costs and benefits, except that unemployment
rates actually declined and the Great Depres-
sion came to an end.
In contrast, we do have data to make a rea-
sonable assessment of the War on Poverty in
terms of employment trends, health and vital
statistics, enrollment in educational programs,
and the incidence of crime. However, none of
these assessments would rise to the scientific
level of establishing cause-and-effect relation-
ships between specific interventions and out-
comes. Therefore, we do not know with cer-
tainty the specific effects of initiatives in health,
civil rights, early education, and other sectors,
nor do we know the specific cost–benefit ratios
that may have accrued from the substantial na-
tional investment in these programs. What was
true then and is still true today is that the pol-
itics of social program implementation did not
mesh well with the scientific requirements for
producing accurate information. At the time,
the overriding concern was to reduce as soon
as possible basic socioeconomic disparities in
society that brought about major social unrest.
Programs were implemented without a careful
analysis of various options or approaches that
might be pursued for reaching this goal. Simi-
larly, telemedicine was introduced and has
been developed to address overriding public
and political concerns with inequities in access
to care, issues pertaining to the inequitable and
uneven distribution of quality of care, and, of
course, the ever-increasing cost of health care.
OBJECTIVES OF EVALUATION IN
HEALTH CARE
As explained earlier, there are two types of
evaluation research in health care. The first is
concerned with testing the efficacy, effective-
ness, and safety of specific medical interven-
tions, devices, or medications. This type of eval-
uation research is typically used by the Food and
Drug Administration to grant approval for pro-
fessional or consumer use. The second type is
the assessment of health program performance
and achievement in terms of stated goals and
objectives. Both types are complex, and both re-
quire the use of rigorous scientific methods.
However, the methodology for testing the safety
and effectiveness of specific devices or inter-
ventions is more direct, simpler, and less prob-
lematic than program evaluation, and it is more
amenable to conventional scientific require-
ments. This is because the experimental variable
is discrete or well defined, its effects are deter-
minable, experimental allocation of cases is pos-
sible, and, with notable exceptions, the out-
comes of interest are usually observable within
the life of the clinical trial.
Health program evaluation is more complex
by virtue of the fact that the experimental vari-
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able(s) are not usually discrete or specific, ex-
perimental allocation is difficult at best, out-
comes are often complex and their attribution
difficult to make, and, midstream/midcourse
changes in the program are often encountered.
Furthermore, health programs have a variety
of effects: direct and indirect, intended and un-
intended, and immediate and delayed. It is
near impossible to capture all these effects
within the life of a sponsored project, which
typically lasts no more than 3 years. Nonethe-
less, program evaluation is essential, and it
serves as an appropriate tool for public policy.
Health program evaluation can serve several
policy objectives: (1) to determine success or
failure of programs in reaching explicit policy
objectives; (2) to ascertain if there is a less costly
alternative to achieve the same objectives; (3)
to determine if the program has undesirable
unintended effects; and (4) to make informed
policy decisions on continuation, termination,
or change in the program, and whether to in-
crease, maintain, or decrease funding for it.
Because its findings are based on scientific
evidence, evaluation research has a significant
effect on “normalizing” new technology in the
academic community and for promoting its ac-
ceptance among practitioners and policymak-
ers. Such evaluation can establish a factual
foundation for the prevailing wisdom. The re-
sults are credible because scientific methodol-
ogy consists of a set of mediating and stan-
dardized practices based on the logic of the
scientific method. Indeed, the evidence pro-
duced by rigorous science provides the “seal of
approval” or “gold standard” for professionals
and the public at large. But, unlike basic re-
search that tests specific theory or explicit hy-
potheses derived from theory, evaluation re-
search is based largely on a conceptualization
and measurement of operating systems in the
real world, and it is aimed at determining their
success or failure in achieving explicit goals and
objectives as well as their unintended effects.
EVALUATION TYPOLOGY
Program evaluation categories are based
largely on measurement feasibility and on the
developmental stage of program implementa-
tion. A comprehensive typology of evaluation
would include: (1) evaluability assessment, (2)
documentation evaluation, (3) process or for-
mative evaluation, and (4) summative or out-
come evaluation.
Evaluability assessment: This can be conducted
when starting or even planning large-scale pro-
grams with a serious intent on having the pro-
gram evaluated systematically subsequent to
its implementation. This type of assessment can
be used effectively to frame the research ques-
tions, to determine the research design re-
quirements, to develop the measurement tools
and the data collection schemes, and to antici-
pate the analytical and statistical methods
needed to manipulate the data. Its importance
derives from the ability to clarify the goals and
objectives of the program at the outset; to 
make explicit the intended effects, both short-
term and long-term; to identify the variables of
interest and how they will be measured; and,
finally to specify the analytical tools for in-
terpreting the findings when they become
available.
Documentation evaluation: This is usually op-
tional, and it consists of a narrative description
of the actual implementation of the program.
To be useful, documentation must include a
true description of the steps, procedures, and
protocols that were used in the implementa-
tion, as well as a reliable assessment of mis-
steps, pitfalls, and problems encountered dur-
ing implementation, and how the latter were
addressed. Obviously, the important rationale
for documentation evaluation is to provide po-
tential new entrants to the field with important
information on successful and unsuccessful ap-
proaches, pitfalls to be avoided, and possible
ways to deal with problems that may arise.
Formative or process evaluation: This begins
once a program is in place. Data can be gath-
ered on its effects on the process of care. This
is referred to as formative or process evalua-
tion.
In many instances, large-scale programs are
based on philosophical principles or policy im-
peratives that call for evaluation. For example,
telemedicine is intended to bring about funda-
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mental changes in the care process, changes
that eliminate not only geographic barriers but
also social and economic disparities in access
to health care. Telemedicine is expected to pro-
vide a less costly alternative to in-person care
by streamlining the care process, reducing the
need for travel, and by providing effective sub-
stitutions in terms of site of care and provider
mix. It is also expected to assist in developing
integrated systems of care as well as in reduc-
ing physician isolation from mainstream med-
icine, thereby improving the overall quality of
care. These expectations have prompted the
Congress of the United States, like public and
private agencies in other countries, to endorse
telemedicine and provide financial support for
telemedicine projects, in sharp contrast to the
more cautious and contemplative approach by
other branches of government, such as the Cen-
ter for Medicare and Medicaid Services (for-
merly the Health Care Financing Administra-
tion), for fear of potentially devastating effects
of paying for pent-up demand for care, espe-
cially in under-served areas and under-served
populations.
Despite the inherent interest in outcome
evaluation (described below), the vast majority
of evaluation research focuses, by necessity, on
process variables. Formative or process evalu-
ation can capture information rich in behav-
ioral, attitudinal, and cognitive changes that
are likely to occur in the short term and can
also be attributed to the program both method-
ologically and logically. Moreover, because
these changes can occur in the short term and
can be logically linked to the intervention, va-
lidity threats are reduced. This makes it more
feasible to rule out certain rival hypotheses or
explanations for observed trends in the data.
Process variables are significant when there is
a clear and logical connection between them as
precursors and the ultimate outcomes in the
sense that, if they occur, the outcome of inter-
est is likely to occur also.
Summative or outcome evaluation: This can pro-
vide definitive evidence regarding the in-
tended effects of a program, when it is based
on rigorous scientific methodology. Moreover,
the clearer, the fewer, and the more explicit or
discrete the objectives of the program, the more
definitive can be the findings from outcome
evaluation. That is why positive results of an
outcome evaluation can be used as the ultimate
justification of programs.
Because striking effects can be produced by
the introduction of new hardware and soft-
ware, there is often acute interest in “techno-
logical fixes” that are easy to install and likely
to produce these effects, especially in the short
term. Unfortunately, the introduction of tech-
nological fixes is also associated with high ex-
pectations, or expectations set at levels that are
difficult to achieve quickly. The irony here is
that moderate success may appear to fall short
of high expectations. Moreover, technological
fixes often have unforeseen and unintended ef-
fects, both positive and negative. These are usu-
ally difficult to account for and to measure.
Insofar as telemedicine is concerned, the most
useful model in summative evaluation for ra-
tional decision or policy making is cost–benefit
analysis. As suggested by Berki, “The funda-
mental effects flowing from the introduction of
telemedicine will be changes in the processes of
producing outputs as well as changes in the out-
puts themselves.”1 Because of these changes, the
alternative method, cost–effectiveness analysis,
would be suboptimal because it would be lim-
ited to ascertaining the least costly alternative to
achieve a given objective; cost–benefit analysis
attempts to maximize the benefits for a given
level of expenditure. Alas, cost–benefit analysis
has the inherent limitation of converting all ben-
efits and costs into monetary values, including
such intangibles as the monetary value of dura-
tion of life, quality of life, and convenience.
However, if its assumptions and metric are ac-
cepted, cost–benefit analysis can provide a ra-
tional basis for answering questions about crit-
ical choices among alternatives that may have
varied and profound effects, including unantic-
ipated effects. This topic is discussed in more de-
tail in T. Reardon’s paper on economics in this
issue.
Summative evaluation, as one might expect,
is particularly important to policy and decision
makers who are inherently interested in the ul-
timate benefits of programs to justify public ex-
penditures and resource allocation decisions at
the institutional, regional, national, and inter-
national levels.




The second generation of telemedicine activ-
ity, which began in the early 1990s in the
United States and several other countries, re-
ceived substantial funding. But, by virtue of 
the political process and perhaps by necessity,
the bulk of the funding was allocated to pro-
gram development rather than research. Of
course, programs had to be planned, designed,
organized, staffed, and launched. Infrastruc-
ture had to be installed, tested, and refined.
Providers had to be recruited and trained, and
patients had to consent and participate. And,
finally operational procedures, protocols, and
logistics had to be developed and routinized.
In other words, the initial requirements for es-
tablishing telemedicine programs were and re-
main quite extensive and time consuming.
Nonetheless, at the same time these programs
were getting organized and launched, most
funding agencies—as perhaps they should—
required them to conduct an evaluation of their
impact within the span of the funding cycle, of-
ten dealing with such complex issues as cost ef-
fectiveness and clinical outcomes.
The political considerations in federal fund-
ing for telemedicine programs in the United
States may have inadvertently preempted the
opportunity to design and execute large-scale,
randomized controlled trials in this field. Pur-
posely or not, we are left with a large number
of programs widely distributed around the
country, but none of them have the resources
or long-term support needed for robust clini-
cal trials. Moreover, the projects that attempted
to collect uniform data sets across several sites
have yet to publish results beyond descriptive
trends. In this field, and perhaps others like it,
there has always been a tension between re-
search and development rather than a comple-
mentary relationship.
Despite, or perhaps due to, a history of sev-
eral decades of dramatic change in the under-
lying technology, we have yet to agree on a uni-
form and precise definition of telemedicine.
This has been exacerbated by a liberal trend in
the imprecise use of such terminology as tele-
health and e-health without a clear consensus
on the delineation of boundaries between them
and telemedicine per se. A uniform agreement
on the content and delineation of boundaries
of telemedicine and other related terms would
seem to be a prerequisite for valid evaluation
of this field. Without such agreement, evalua-
tion will remain largely project specific and,
therefore, of limited generality.
Today, what we call telemedicine, telehealth,
or e-health encompasses any existing or pro-
posed configuration of technology, organiza-
tion, and human resources. It also includes sin-
gle or multiple clinical, educational, and public
health applications. In this regard, no single or
standard referent exists as to what telemedicine
does or does not represent. From one perspec-
tive, this lack of a precise definition compro-
mises our ability to evaluate the true concept
in full “fidelity.”2 Accordingly, whatever defi-
nitional imperfections exist in the configuration
of a particular system under investigation will
likely mask or mitigate the true effects of the
telemedicine concept in its optimal form.
INTERPRETING CURRENT 
EMPIRICAL EVIDENCE
To start out, we present a synopsis of the con-
clusions reached by other investigators who
have conducted literature reviews (a review of
reviews) on the evaluation of this field. A num-
ber of published comprehensive and painstak-
ing literature reviews of the work done in this
field are available and are referenced later. The
results of these reviews will be used as the log-
ical foundation for developing alternative
strategies for future investigation and analysis
of evidence. Finally, we conclude with a dis-
cussion of options for future evaluative re-
search and analysis of the available empirical
evidence.
In brief, a literature review focusing on em-
pirical research in telemedicine to date reveals
that the research is not based on a precise and
uniform set of parameters. Hence, this body of
knowledge, although substantial in volume, is
segmented and inconclusive. It is segmented in
the sense that much of it focuses on specific ap-
plications rather than integrated systems of
care related to patient care as well as provider
and client education. Consequently, much of
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this information has little to do with the sys-
temic effects of telemedicine.
Furthermore, even well-designed experi-
mental studies can be misleading. For example,
diagnostic accuracy has been typically deter-
mined on the basis of observer agreement be-
tween in-person care (the gold standard) and
care provided by telemedicine. As Koran3
pointed out, however, physicians tend to dis-
agree with each other “once in ten cases, and
often . . . one in five cases, whether they were
eliciting physical signs, interpreting roentgeno-
grams, electrocardiograms, or electroencepha-
lograms, making a diagnosis, recommending
treatment, or evaluating the quality of care.”
Hence, reliability based on “agreement” should
not be equated with accuracy.
It is interesting to note that, in an attempt 
to control interobserver variability, some re-
searchers in this field have limited the number
of observers to one or two who make two ob-
servations (telemedicine and in person) on 
the same subjects. This creates an even larger
problem than the one it purports to resolve,
namely the lack of independence in the data.
Without independence, it is inappropriate to
conduct any statistical analysis or to test any
hypotheses.
After years and scores of attempts to develop
and evaluate telemedicine initiatives and pro-
grams, the complaint continues to be found in
the literature that the quality of evaluation
studies is poor. As early as 1980, Bashshur4
lamented the fact that in the late 1960s and
early 1970s, there had not been a broad-rang-
ing, systematic effort to address all the basic
and pertinent issues in the assessment of
telemedicine and, further, “policy decisions re-
garding the funding of telemedicine . . . utilized
a mixture of anecdotal and inconclusive em-
pirical findings.” In the mid-1990s, the National
Library of Medicine recognized a national need
for robust telemedicine evaluation methodol-
ogy and called for the Institute of Medicine to
develop it.5,6 The report discussed general is-
sues and suggested general guidelines but not
an explicit framework and concrete guidelines
for telemedicine evaluation.
DeChant et al.7 suggested a “staged ap-
proach” to deal with “the great variety in
telemedicine applications and . . . new infor-
mation systems for health care delivery (that)
pose(d) challenges to traditional methods of
technology assessment.” A systematic review
of over one thousand articles evaluating tele-
medicine cost-effectiveness revealed “only a
few” controlled studies, and the vast majority
did not produce the requisite scientific evi-
dence.8 A review and critique of literature per-
taining to evaluation of telehealth “solutions”
called for consistency in the nature of evalua-
tion activities “—if achievable—” and also sug-
gested that this would certainly not occur in the
short term.9 The DeChant report concluded
that “most telehealth applications are either not
well evaluated, or are evaluated in an ad hoc
manner.” A review of clinical outcomes in
telemedicine initiatives concluded that in only
a small number of studies does evidence of its
benefits exist, and there is need for further ran-
domized controlled trials.10
The 2001 Report to Congress on Telemedi-
cine indicated a lack of statistical evidence in
most of the studies. It expressed “hope” for
more statistically robust studies in the near fu-
ture.11 In 2002, an editorial in the Journal of the
American Medical Informatics Association sug-
gested that “the (telehealth) literature does 
not contain an adequate evaluation of telemed-
icine despite years of application of the tech-
nology and several calls to action.”12 A litera-
ture review of telemedicine cost-effectiveness
and patient satisfaction also concluded that, for
the former, “there is no good evidence that
telemedicine is [or is not] a cost effective means 
of delivering health care” (brackets added) 
and, for the latter, methodological deficiencies
(small sample sizes, context, and study de-
signs) limited the generality of the findings.13,14
Another review reported the scarcity of good-
quality studies providing the evidence for the
benefits of telemedicine.8,15 A review of clinical
and educational telepsychiatric applications
did not incorporate cost studies because the
quality of data in the literature was “subop-
timal and little . . . has been collected in a 
systematic, controlled prospective fashion.”16
And, “more short- and long-term quantitative
and qualitative research is warranted on clini-
cal outcomes, predictors of satisfaction, costs,
and educational outcomes.” Drake raises the
basic question about the future in his literature
5690_07_p296-316  7/6/05  2:14 PM  Page 302
TELEMEDICINE EVALUATION 303
review of telemedicine valuation in 2003.17 He
concludes, “Even when mature evaluation
techniques are extrapolated to telemedicine, af-
ter the studies are published, the most impor-
tant question appears to remain: Is telemedi-
cine technology worth advancing, and how as
a society do we decide?”
These studies and conclusions represent re-
cent systematic reviews of telemedicine evalu-
ation studies. We may draw the general con-
clusion, therefore, that with few exceptions the
research in this field has yet to produce an ad-
equate body of empirical findings that rises to
the level of conclusive evidence as traditionally
defined. And, therefore, in a strict sense, we
cannot ascertain with a reasonable degree of
certainty the precise or specific effects of
telemedicine on access, cost, and quality or the
interaction between these effects, despite the
importance of these issues from a public pol-
icy standpoint.
Nevertheless, the bulk of the research evi-
dence to date has demonstrated the feasibility
of telemedicine in almost all clinical and diag-
nostic applications. More than a decade ago,
Grigsby and associates18 reported that telera-
diology is “effective across all specialties.” In-
deed, the question of feasibility of telemedicine
in all other clinical applications has been put to
rest for quite some time, albeit at different lev-
els of confidence for different applications. In-
terestingly, clinical applications have been clas-
sified by level of maturity on the basis of
several performance measures and attributes,
including volume and quality of research find-
ings, demonstrable technical feasibility, diag-
nostic accuracy, specificity, clinical outcome,
and cost effectiveness.19 According to this clas-
sification, teleradiology and telepathology oc-
cupy the first tier, and are labeled as “mature”
applications. The second tier, or “maturing”
applications, consists of telepsychiatry, tele-
dermatology, telecardiology, and teleopthal-
mology. All other applications are in the third
tier, and labeled as “emerging” applications. Of
interest here is the fact that all research find-
ings pertaining to clinical effectiveness across
a variety of applications and at various levels
of maturation are linked to the specific tech-
nology that was used in the application, and all
technical failures and limitations are totally at-
tributable to specific sets of technologies that
were used and have been improved since.
Hence, no inherent limitations have been re-
ported.
Finally, on careful reflection, several obser-
vations can be made about the evaluation lit-
erature.
• None of the systems or programs that were
evaluated in the United States or other coun-
tries had fully exploited the technological 
capabilities at their disposal. Indeed, for a 
variety of reasons, all programs have sub-
stantially underused the capabilities of the
available technology. Hence, any economic
assessment that takes capital cost into ac-
count but does not incorporate sensitivity
analysis under various assumptions of re-
source capacity, utilization volume, and level
of maturation, learning curve, or steady-state
operation is likely to underestimate the po-
tential return on investment. Because capital
cost is fixed, it is obvious that the more fre-
quently and the more efficiently the program
is used, the more favorable would be the re-
turn on investment. Moreover, given condi-
tions of under-use, the logical question con-
tinues to be whether simpler and lower-cost
technology (essentially, lower investment)
could be more fully, and therefore, more
cost-effectively used. But even this argument
may have flaws because scale is important,
and some minimal level of investment and
operational size may be necessary to estab-
lish a viable program.
• In addition, nearly all telemedicine projects
have missed significant opportunities to use
the enormous capabilities of available infor-
mation technology to create truly integrated
health-care delivery systems. The underly-
ing technology provides not only ready con-
nectivity between various parts of the deliv-
ery system but, perhaps more importantly,
ready access to information from various
sources within and outside the institution for
various components of patient care, proto-
col-driven disease management programs,
and clinical decision support. The effective
use of these rich capabilities and their inte-
gration into a single organization or system
of care should reduce so-called errors, en-
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hance efficiency, minimize unnecessary du-
plication and waste, and streamline the care
process.
Nearly all projects had narrowly defined
clinical or educational objectives or functions
and specific target populations. This left un-
attended important questions pertaining to
the full potential of the information technol-
ogy at their disposal, similar to having a
desktop computer, but using it only for elec-
tronic mail. While it makes perfect sense to
use the computer for e-mail, one should not
lose sight of the other numerous capabilities
and the missed opportunities when they are
not fully exploited. The ramifications for
cost–benefit ratios are substantial.
• Given the observed limitations in the scope
of the applications to date, it is not surpris-
ing that we have yet to assess adequately the
broader systemic effects of telemedicine on
use of service, referral and admission rates,
access to care, quality, and cost of care in a
way that allows true generalization about
these effects. We have yet to achieve an in-
depth understanding of the tradeoffs and in-
teractions between these various effects, as
discussed elsewhere in this paper.
EVALUATION RESEARCH: 
PROPOSED APPROACHES
The proposed approaches for valid evalua-
tion of telemedicine are discussed here in terms
of (1) prerequisites for optimal evaluation; (2)
research design requirements; and (3) analytic
tools for causal inference.
Prerequisites for optimal evaluation
Evaluation of telemedicine programs has
been significantly hampered by the absence of
optimally operating systems that have pro-
gressed sufficiently along the learning curve to
permit a valid evaluation under optimal or at
least steady-state conditions. Evaluating pro-
grams under these circumstances runs the risk
of simply reflecting imperfections in design or
implementation rather than inherent flaws in
the basic concept or a necessary failure in the
intrinsic capability of the intervention. Fur-
thermore, even when a program is adminis-
tered in optimal fashion, one must separate the
contextual effects from the experimental ef-
fects. To address this problem, Campbell20 pro-
posed the “climax model,” which calls for eval-
uating programs only after they achieve a
steady state of operation and contain all the in-
tended core elements and capabilities of the
program. The use of this model would assure
that programs have sufficient fidelity in terms
of strength, volume, and stability as prerequi-
sites for assessing their true effects.
At the same time, it is clear that a telemedi-
cine program constitutes an innovation “bun-
dle” rather than a single categorical interven-
tion. When the concept of “innovation bundle”
was introduced by Rogers and Shoemaker,21 a
precise definition was not offered. But it stands
for a set of attributes, not all of which may be
innovative. In telemedicine, for example, cer-
tain traditional clinical and communication
practices are likely to be maintained and
“mixed in” with the new mode of delivery. The
broader medical care environment where these
systems are installed is not likely to alter all es-
tablished practices and routines simply by
virtue of adding telemedicine to its repertoire
of services. In other words, neither providers
nor clients would alter all their traditional be-
haviors simply by virtue of having telemedi-
cine available to them.
Nonetheless, an innovation bundle is ex-
pected to produce effects for the entire bundle
that are likely to be incremental in nature. Sim-
ilarly, the telemedicine bundle is likely to pro-
duce a variety of effects that are associated with
various subsets of variables. These effects may
represent tradeoffs rather than be unidirec-
tional and additive. For example, telemedicine
presents clear transportation/communication
tradeoffs, which may increase access and en-
hance quality while reducing opportunity cost.
But we have yet to explain or understand
what happens to cost when accessibility is im-
proved. For example, would an improvement
in access to care lead to a commensurate in-
crease in demand, or even pent-up demand,
and increase the risk of what economists call
the “moral hazard,” or the tendency to use
medical services more because of decreased
barriers to use? Would the availability of
telemedicine lead to an increase in “provider-
5690_07_p296-316  7/6/05  2:14 PM  Page 304
TELEMEDICINE EVALUATION 305
induced” demand on the part of those seeking
to enhance their revenues from the use of the
technology? Would telemedicine initiatives
displace the scarce medical resources available
in a highly constrained rural environment, and
thereby inadvertently diminish rather than en-
hance the available resources in those areas?
Would telemedicine be likely to produce the
paradoxical effect of promoting quality of care
in under-served rural areas only to reduce the
need for telemedicine over time? In other
words, would its success lead to its ultimate
demise? These and other important questions
have yet to be addressed in definitive and com-
prehensive ways. Indeed, we have yet to under-
stand whether success or failure in a specific
clinical application or subsets of applications
can be generalized to other applications or to
the entire system of care. For instance, does suc-
cess in teleradiology indicate success in other
clinical applications or of entire programs that
offer a variety of clinical services? Or, alterna-
tively are telemedicine systems more than the
sum of their parts?
Hence, the evaluation process has to be suf-
ficiently refined and detailed to enable a valid
analysis of the specific effects of the “newer”
components as well as combinations of new
and old ones, and it must be able to isolate
telemedicine effects independently from con-
textual or other effects. This will not be easy,
but it is particularly important in assessing
telemedicine’s effects on cost, quality, and ac-
cess and the interactions among them.
While the calls for health care reform in the
United States and elsewhere ebb and flow, re-
flecting the prevailing political climate, there is
near-universal and omnipresent agreement on
three related national goals: (1) Access to care
should be improved, if not assured, to all peo-
ple in need of care; (2) cost should be contained
as much as possible without compromising
people’s health or safety, and, (3) quality
should be maintained in all places, if not im-
proved. With these goals in mind, it is under-
standable that telemedicine would remain on
the agenda for health care reform for the fore-
seeable future.
Proponents have argued that telemedicine
could accomplish all three goals effectively
and efficiently, not only for rural and other 
isolated populations, but also for the home-
bound and the institutionalized, as well as ur-
ban and poorly served populations. However,
some critics have expressed concern that tele-
medicine may produce adverse effects by de-
creasing accessibility (by displacing rural
providers); increasing total cost (by unleashing
consumer pent-up demand and potential pro-
vider-induced demand); and compromising
quality (by relying on a technology that may
be a poor substitute for in-person care). Inter-
estingly, when juxtaposed, the hypotheses of
the advocates and the critics are enantiomor-
phic, that is, they mirror one another, thereby
demonstrating their centrality and the need to
subject them to rigorous scientific testing.
Research design
Two issues must be made clear in considering
the choice of appropriate research designs for
telemedicine program evaluation. First, the con-
trolled experiment is the ideal method for eval-
uation research because it calls for the random
assignment of test subjects to experimental and
control groups, blind administration of the ex-
perimental variable, and pre- and post-interven-
tion measurement. No doubt, the controlled ex-
periment is the most powerful tool for achieving
objective and valid results for policy making and
program implementation. Weaker methods
yield equivocal results that could be manipu-
lated by program managers and decision mak-
ers. Hence, all things being equal, the controlled
experiment is the preferred method for (1) test-
ing explicit hypotheses, (2) ruling out rival hy-
potheses or other explanations for the observed
phenomena, and (3) establishing cause–effect 
relationships between the specified variables.
When one or more requisites of a controlled ex-
periment cannot be obtained in a given situation,
quasi-experimental designs and observational
studies can be used, which ideally would mimic
the controlled experiment to the extent feasible.
This is true for simple medical interventions,
such as new devices, new medications, or new
procedures, as well as for medical programs,
such as community health centers, regional med-
ical programs, and, of course, telemedicine.
In brief, the essential feature of a controlled
experiment or randomized controlled trial is
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the active participation of the experimenter in
randomizing subjects, administering the treat-
ment or program intervention, and measuring
differences between the experimental and con-
trol groups before and after the intervention.
As we discuss later, randomized controlled tri-
als may not be feasible in this field.
Second, the absence of knowledge or method-
ological sophistication is not hampering the
progress of research in this field. Such knowl-
edge exists, and the requisite methodological
tools are in hand. We do not need to invent new
methodology. For example, in complex evalu-
ations, factorial designs enable the detection of
differential effects of various combinations of
variables, including characteristics of individ-
uals using the service (old versus young, male
versus female); various levels in severity of ill-
ness, and provider mix (generalist versus spe-
cialist). Subsequently, the design enables re-
searchers to concentrate on features that either
singly or in combination produce the greatest
effects. In the real world, however, it is im-
practicable and, in some situations, impossible
to conduct controlled experiments to evaluate
telemedicine programs as total entities. Among
other things, the requirements of scientific in-
quiry on the one hand and the political, legal,
and ethical imperatives on the other are not
consistent, as discussed earlier. Laws and reg-
ulations governing individual autonomy
through informed consent and the proscription
of harmful interventions are appropriate in a
civilized society, although some of these regu-
lations can create formidable difficulties in re-
search.
Human subjects have the right to refuse par-
ticipation in any study that observes them di-
rectly, collects information about them, or uses
personal information already available. Fur-
thermore, they have the right to withdraw their
consent at any time during or after the conclu-
sion of a study, and, in certain instances, to
jump experimental allocation. And when the
intervention may be deemed beneficial, it may
be unethical to withhold it from those in need.
It is not uncommon for researchers to have to
nullify or diminish the effects of the experi-
mental variable by promising remediation for
ill effects as a result of participating in the
study. For example, in the RAND Insurance
Study, participants received remuneration for
higher out-of-pocket cost that resulted from
their assignment to health insurance plans with
a high co-payment.22
It is important to add that these issues (with-
drawal of patients, patient crossover, and the
ethical issues when the interventions are found
to be harmful or beneficial before the planned
end of the study) occur frequently in clinical
trials. Techniques such as application of the
“intention-to-treat” principle, survival analysis
techniques, and independent study safety com-
mittees are available.23
These issues aside, random assignment of
patients to experimental and control groups is
not possible when the entire population of
telemedicine users is extremely limited. In-
deed, small sample size is one of the major ob-
stacles in conducting randomized controlled
trials as well as sample surveys to evaluate the
impact of telemedicine programs. Further, sit-
uational or contextual factors cannot be held
constant to rule out rival hypotheses given the
empirical diversity of telemedicine programs
produced by local variations in administration,
variations in clinical applications and in orga-
nizational and staffing configurations, varia-
tions in the clinical competence of providers,
and the continuing evolution in the underlying
technology.
There are several other impediments to the
use of experimental designs in telemedicine re-
search. First, we have yet to agree on the pre-
cise scope of the program to be evaluated and
to differentiate between the overall goals of the
program and those of the specific applications
within it. Telemedicine programs can range
from single specialty service within a single de-
livery system, such as teleradiolology, to a mul-
tispecialty, multisite network that offers a full
range of medical and diagnostic services. De-
spite their intuitive appeal, full-service pro-
grams are difficult to implement. Second, as
mentioned before, the prevailing laws and reg-
ulations covering the use of human subjects in
research often challenge randomization rules,
which blindly assigns subjects to an experi-
mental or control group, do not permit subjects
to “jump” or transfer from one experimental al-
location to another, and do not allow adminis-
trators or project managers to make midcourse
5690_07_p296-316  7/6/05  2:14 PM  Page 306
TELEMEDICINE EVALUATION 307
changes in the content of the program—espe-
cially in terms of key variables that may alter
the outcomes. Such changes include techno-
logical configurations (in terms of hardware
and software), human resources and staffing,
and the organizational structure of the pro-
gram.
Beyond these serious difficulties, the evalu-
ation of telemedicine faces some unique prob-
lems in terms of the nature of the experimen-
tal variable, or the unit of analysis. The usual
units of analysis, as well as units of observa-
tion, that have been reported in the telemedi-
cine literature typically consist of individual
medical visits or encounters. The more appro-
priate units of analysis in telemedicine research
may consist of episodes of care or illness
episodes to be used in comparing telemedicine
with in-person care. Indeed, more useful and
valid information about the effects of telemed-
icine on utilization and cost would be captured
when using episodes of care or episodes of ill-
ness rather than single visits or encounters.
This is because episodes can capture more in-
formation for assessing the contributions of
telemedicine. Additionally, episodes can be
compared between the two modalities of care,
telemedicine and in-person, while controlling
for severity of illness. They can provide com-
parative information on the number and dura-
tion of visits, intensity of care, substitutions (be-
tween sites and providers), timeliness of care,
waiting time, and outcomes. Their use would
enable us to ascertain whether or not telemed-
icine has a significant effect on the process and
outcome of care. For example, among other
things, it would reveal whether or not the use
of telemedicine resulted in more timely diag-
nosis, fewer visits, fewer and shorter hospital-
ization, shorter illness episodes, and ultimately
a more successful health outcome.
As many observers have pointed out, the
telemedicine concept continues to evolve in
scope, application, and underlying technology.
Hence, it is futile to evaluate it as a fixed en-
tity. It can represent different things to differ-
ent people at different times and in different
settings. Nonetheless, for policy purposes,
evaluation may have to focus on the general at-
tributes of the practice of telemedicine, if such
parameters exist, or on telemedicine as a whole
if it is considered a single entity, to assess its
overall merit and how it fits into the health sys-
tem.
The gains or losses that might accrue from
telemedicine are likely to vary by the intended
target or user, the nature of the application, and
the specific technological configuration that is
used. Moreover, the benefits and costs of
telemedicine should be viewed from the varied
perspectives of providers, clients, and society
at large. Each perspective has concerns that
must be identified and addressed in the design
of the study. The specific applications also must
be taken into account, such as clinical, educa-
tional, and managerial programs. Finally, the
study must consider the specific technological
design and configuration in use, for instance,
whether it is a synchronous or asynchronous
connection, bandwidth, and peripheral de-
vices. This multifaceted approach can be repre-
sented by a three-dimensional model adapted
from Donabedian,24 as shown in Figure 1.
The first dimension in the model is made of
the various applications that encompass the
different specialty areas of medical practice as
well as medical education and public health. If
we take the nomenclature and purview of tele-
health or e-health seriously, we must include
all areas of public health, including disease sur-
veillance, epidemiology, health education and
health behavior, and health administration.
FIG. 1. Three-dimensional model for telemedicine eval-
uation.
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The second dimension has to do with the 
specific perspectives from which an evaluation
can be conducted, specifically those of clients,
providers, and society at large. Obviously, de-
spite some commonalities among them, the con-
cerns of clients (or consumers) might differ
from those of providers or of society at large.
Each perspective must be measured separately.
For example, on the question of cost, clients may
be interested in out-of-pocket cost, whereas
providers may be interested in revenue gener-
ation and return on investment. Societal interest
may relate to total cost, equitable distribution
of health-care resources, and meeting unmet
needs of the population. Thus, even when con-
cerned with the same basic issues, providers,
clients, and society may approach them differ-
ently because their stakes are different.
The third dimension represents various tech-
nological systems and configurations in use, in-
cluding synchronous online systems, asyn-
chronous store-and-forward systems, various
modalities of transmission (wired, wireless),
bandwidth, and peripheral devices for diagno-
sis and treatment.
This model provides a systematic taxonomy
or framework for interpreting and integrat-
ing research findings from different empirical
studies, while leaving researchers to pursue
their particular interests in addressing a vari-
ety of research questions in their respective do-
mains. Ultimately, the findings from individ-
ual studies must be combined in a coherent set.
This proposed model allows for such a compi-
lation of the empirical evidence in a flexible and
ongoing manner while at the same time pro-
viding the requisite structure for accumulating
evidence from various studies performed by
different investigators at various times. The
distribution of “completed” compartments can
also serve to identify research gaps that need
to be filled.
The individual compartments or cubes within
the three-dimensional matrix can be viewed
singly or in various combinations. For instance,
one researcher may choose to investigate the
quality of diagnostic images and their cost-
effectiveness in teleradiology, using store-and-
forward technology. Of course, this would 
be from a provider perspective. Another re-
searcher may assess the systemic effects of a
telemedicine program on access, cost, and qual-
ity of care from a societal perspective. The “ex-
tracted” cube in Figure 1 represents a clinical
application from the client’s perspective using
synchronous technology. For example, this re-
search might involve a remote diabetic patient
sending in blood sugar readings to an en-
docrinologist and receiving information on
what type of meals to prepare. In another sce-
nario, the patient would submit blood sugar
readings, exercise regimen, and other related
information to a Web site that would respond
with the appropriate dietary information.
The findings from each study or set of stud-
ies on the same topic may be used to fill in one
compartment or cube in the model, which can
be subsequently added to findings from other
studies for a cumulative total that combines all
other studies in the other compartments until
the picture is complete. In the end, this cumu-
lative process would begin to answer some of
the pressing questions in the field. It would also
serve to identify gaps in research. However,
this would not be a simple or straightforward
process, since a meaningful matrix of findings
has to be based on compatible studies that meet
common methodological standards.
Typology of research questions
As illustrated in Table 1, there are essentially
two types of research questions that are ap-
propriate for telemedicine evaluation. The first
derives from the biomedical or clinical field,
and it encompasses issues of clinical effective-
ness, efficacy, and safety. More specifically,
biomedical research seeks to ascertain the ac-
curacy, precision, reliability, and sensitivity as
well as safety (or side effects) of specific tech-
nological components in providing diagnostic
or treatment information. Insofar as telemedi-
cine is concerned, the basic goal of biomedical
research is to determine the extent to which
specified technological components meet or ex-
ceed clinical standards of performance as com-
pared with in-person observation and mea-
surement. The second type or set of research
questions derives from health services re-
search. Here, the questions are typically posed
after the conclusion of biomedical or clinical re-
search, and the technology is certified as safe
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and effective. Indeed, in a perfectly logical
world, health services research would begin
when biomedical research ends.
Whereas biomedical research is indispens-
able and must be continued, it seems to be
faced with overwhelming odds against prov-
ing anything definitive on a permanent basis,
in relation to the clinical effectiveness of
telemedicine technology. This is due to contin-
ued technological developments that reduce or
eliminate observed imperfections in the tech-
nology, as the field continues in its press to find
effective substitutes for the five senses. The
technological horizon keeps expanding. In
turn, these technological improvements have a
direct impact on clinical effectiveness as well
as on cost–benefit ratios, and the tradeoff be-
tween cost and quality. In brief, technological
advances tend to obviate limitations in diag-
nostic or therapeutic effectiveness attributed to
specific technologies.
Questions and hypotheses stemming from
both biomedical and health services research
can be readily translated into specific measures
to be used in data collection and subsequent
analysis. Some of these measures are simple
and straightforward and some are not. All of
them require validity and reliability testing to
ensure that they actually measure what they
purport to measure in a consistent fashion.
Telemedicine literature already contains sev-
eral standardized measures borrowed from so-
cial science research, which may be used by re-
searchers in this field.
Telemedicine evaluation: revised strategy
Other things being equal, the strategy of
choice in telemedicine evaluation would con-
sist of a large-scale research program that uses
rigorous scientific methods to investigate the
various dimensions of telemedicine as well as
the interactions between them. However, this
is not likely now or in the foreseeable future.
This situation leads us to offer an alternative
that can be pursued immediately; namely, to
ascertain in a systematic manner the weight of
the available evidence and new findings as they
become available.
In this section, following a brief statement
pertaining to the contextual framework of
telemedicine development and its expected
role in improving access to care, we focus first
on the notion of cause-and-effect and its mea-
surement. Finally, we propose and discuss a
new strategy that might be appropriate for as-
sessing the impact of telemedicine on access,
quality, and cost of health care. But, for illus-
trative purposes and because issues of cost and
quality are considered in separate papers, we
limit our consideration here to the association
between telemedicine and access to care.
CONTEXTUAL BACKGROUND
Concern for the inequitable geographic dis-
tribution of medical care was expressed as early
as the mid-19th century when the (then)
nascent American Medical Association charged
state medical societies to assess the geographic
availability of physician care. Several states re-
ported that physicians were fewer and less
likely to have adequate medical training in
rural areas when compared with those in ur-
ban areas. Development and diffusion of ad-
vanced technologies, such as the automobile
and telephone in the late 19th and early 20th
centuries, reshaped the argument regarding ge-
TABLE 1. TYPES OF RESEARCH IN TELEMEDICINE, RESEARCH QUESTIONS, AND MEASURES
Research
questions Measures
Biomedical research Safety, effectiveness Precision, accuracy
specificity, reliability
Health services Access, quality, Utilization, referral,
Health care cost convenience, opportunity
cost, etc.
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ographic access to care. But, the emergence of
specialized medicine and office/clinic/hospi-
tal–based medical care in the mid–20th century
exacerbated the geographical disparity in the
distribution of medical-care resources between
rural and urban areas, as well as between de-
veloped and developing countries.
Historically in the United States, attempts to
redress the inequitable geographic distribution
of medical care, such as the Sears Roebuck
Foundation’s Community Medical Assistance
Program,25 the Hospital Survey and Construc-
tion (Hill-Burton) Act,26 and the National
Health Service Corps created as part of the U.S.
Public Health Service under the Emergency
Health Personnel Act,27 were among the lead-
ing initiatives aimed at redressing the prevail-
ing geographic disparities in availability of
health-care resources. But all were met with
mixed results and generally limited success,
especially as they pertain to specialty care.
Thus, the excitement that met the introduction
of telemedicine initially in the early 1970s and
now was based in large part on past failures to
redistribute medical-care resources physically
and the emerging virtual distribution that
would provide under-served populations with
ready access to medical care when needed. This
virtual distribution of health resources is ex-
pected to diminish opportunity cost for clients
or patients, and it should enhance quality of
care and hence improve health status. Other
factors contributing to the excitement include
the potential for creating integrated medical
systems and reduction in so-called medical 
errors.
CAUSAL INFERENCE
Any evaluation of the impact of telemedicine
on access implicitly or explicitly assumes a cause-
and-effect relationship. For philosophers, the
notion of cause and effect is murky at best.
Hume and others argued, for example, that we
can never know with certainty whether two
events are causally related. There is simply a
constant temporal conjunction observed re-
peatedly, and, “therefore what we term ‘causal-
ity’ can be nothing other than mere constant
conjunction of the idea of the cause with that
of the effect,” and this is known from experi-
ence.28 But we are living in the real world, not
that of philosophers, and we need to know to
our satisfaction whether there is a causal asso-
ciation between telemedicine and access and,
more specifically, the direction and magnitude
of that association.
Here, we may be informed by a similar, per-
haps simpler, situation that occurred in the de-
velopment of epidemiology; namely, the evo-
lution of criteria for “causality” between a
disease agent (virus, bacterium, parasite, etc.)
and a disease. Initially, following the discover-
ies of Pasteur in the late 19th century, the so-
called Henle–Koch “postulates” were used.
These postulates stated that an agent is a cause
of a disease if it is present in all the affected
persons (“necessary” cause), it is absent in
healthy subjects (“sufficient” cause), and it can
be inoculated into an animal to induce the same
diseases that it causes in humans. However,
implementation of these criteria in epidemiol-
ogy proved impracticable, if not impossible.
Later, Sir Austin Bradford Hill29 proposed
nine criteria of causation as minimal conditions
to establish a causal relationship between two
events. Nonetheless, he cautioned that “none
of these nine viewpoints can bring indisputable
evidence for or against a cause and effect hy-
pothesis. . . . What they can do, with greater or
less strength, is to help answer the fundamen-
tal question—is there any other way of ex-
plaining the set of facts before us, is there any
other answer equally, or more, likely than
cause and effect?” He even went so far as to
suggest that none can be considered as a sine
qua non of causality.” However, Rothman30
points out if the “cause” does not precede the
effect, that indeed the temporality criterion is
indisputable evidence that the association is
not causal.
While the criteria established by Hill (and
elaborated by others) were developed as a re-
search tool in epidemiology, they may be
equally applicable in other social sciences seek-
ing to establish causal relationships among 
social phenomena, especially when it is not 
feasible to conduct prospective large-scale, ran-
domized controlled trials. It must be remem-
bered, however, that Hill’s criteria and, histor-
ically, discussions on causality, have proceeded
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once a statistically significant relationship be-
tween a potential causal factor and a disease
has been found. In at least one instance, this
threshold was ignored for apparent political
purposes by a government agency. This led to
considerable criticism from the scientific com-
munity on the role of environmental carcino-
gens in a “cancer epidemic.”31
Armed with these criteria, epidemiologists
have been able to investigate suspected single-
and multifactor causal relationships and to ad-
vise the public and private health sectors on
health policy decisions. Essentially, the process
is one of “triangulation,” or the application and
combination of several research methodologies
in the study of the same phenomenon.
By combining multiple sources of data, the-
ories, methods, and empirical materials, tri-
angulation may overcome the weakness of re-
search design or intrinsic biases that come
from small studies with inconclusive find-
ings. Researchers are able to triangulate, or
draw significant conclusions in terms of the
convergence of findings, from various stud-
ies and methodological approaches to the
same topic. But, even here certain criteria
have to be met.
Addressing the field of human–computer in-
teraction, Mackay32 suggests that, to mature as
a field, there must be a shared research context
and the need for triangulation: “using different
techniques to operationalize behavior while at-
tempting to measure the same phenomenon . . .
which greatly increase the generality and con-
struct validity of the findings.” A study of air-
traffic controllers, for example, included bio-
logical analysis of sleep patterns, laboratory
experiments of different user interface strate-
gies, computer simulations in the use of new
tools by controllers, cognitive models of air
traffic control’s activities, and ethnographic
studies of controllers at work.33
Triangulating among various forms and
sources of data means that if an observation
holds across a variety of contexts viewed from
different research perspectives, then we are
more confident of the integrity of the finding.
It has also been suggested that through the tri-
angulation of qualitative and quantitative data,
a “more complete, holistic, and contextual por-
trayal of the research issue is captured.”34–36 A
number of triangulation types have been iden-
tified:
• Data triangulation: The use of multiple data
sources to help understand a phenomenon.
• Methods triangulation: The use of multiple
research methods to study a phenomenon.
• Investigator triangulation: The use of multi-
ple investigators in collecting, analyzing,
and interpreting the data.
• Theory triangulation: The use of multiple
theories and perspectives to help interpret
and explain the data.
Although one might be tempted to down-
play or even disregard a conclusion from a sin-
gle data source, a conclusion derived from tri-
angulation from multiple sources is more
credible and can be valuable and meaningful.
Triangulation of information can allow even
statistically limited or weak conclusions drawn
from one source to be compared with conclu-
sions drawn from other sources. In the follow-
ing section, we attempt to demonstrate the use
of theoretical triangulation as it might apply to
assessing the impact of telemedicine on access.
EVALUATING TELEMEDICINE AND
ACCESS: A NEW STRATEGY
Generally, access refers to the ability of pa-
tients to use appropriate health resources in a
timely manner. The concept summarizes a set
of specific dimensions that describe the “fit” be-
tween a patient and the health-care system.37
The Institute of Medicine5 suggested that ac-
cess can be enhanced by increased availability
of health information.
The realization of the need and appeals for
scientific evaluation of the impact of telemedi-
cine on access is longstanding. Nevertheless,
the appraisal of telemedicine access-evaluation
reveals few studies that provide definitive con-
clusions, as is the case for evaluating cost, qual-
ity, and other aspects to telemedicine. In fact,
valid reasons have been offered for the seem-
ing inability to evaluate the association be-
tween telemedicine and access adequately.
These include the lack of mature telemedicine
programs due largely to the recency of the in-
5690_07_p296-316  7/6/05  2:14 PM  Page 311
BASHSHUR ET AL.312
novation, as well as limited funding duration
in some instances. Also complicating matters 
is an inherent lack of stability and the chang-
ing nature of telemedicine, reflecting the inclu-
sion of innovative technology as it becomes
available and applications in new areas. Addi-
tionally, to date there have been few if any
large-scale telemedicine experiments specifi-
cally designed and funded to conduct ran-
domized controlled trials to determine the var-
ious effects of telemedicine on cost, quality, and
access and interactions among these effects.
Given these conditions, telemedicine may
not lend itself to traditional methods for
demonstrating cause and effect. Consequently,
it is time to re-evaluate the concept and strat-
egy of evaluation in this field.
A triangulation process may be the appro-
priate tool for interpreting the extant evidence.
The “triangulation process” refers to conclu-
sions from a number of sources within each cri-
terion of causal inference. In turn, the total re-
sults from these triangulations produce a valid
basis for reaching closure on the intended ef-
fect. The components of the proposed triangu-
lation process are illustrated in Figure 2.
The criteria in Figure 2, also listed below for
discussion, are adopted from epidemiology
and adapted for the purpose of assessing
telemedicine.
Temporality
This criterion may imply a concomitant
“temporal” relationship with the duration of
the telemedicine program; that is, the longer
the program has been in existence, the greater
will be the observed impact.
Gradient
This refers to the increase or decrease in ac-
cess for persons using telemedicine versus
those who use in-person care for the same con-
ditions and the same severity of illness. Alter-
nate measures include various aspects of op-
portunity cost, including travel costs, travel
time and distance, lost wages, and conve-
nience. It implies that: (1) the increase in access
to medical care, however measured, follows the
introduction/availability of telemedicine and
is not the result of simultaneous reduction in
travel costs through improvement in trans-
portation or other reductions in opportunity
costs; and (2) the “stronger” the telemedicine
program (reputation of consulting center, dif-
fusion of information regarding program, ac-
ceptance by physicians and administrators),
the greater will be the impact on access.
Consistency
This pertains to the degree of consensus on
the impact of telemedicine on access obtained
from a wide variety of people, places, settings,
and applications. With specific reference to ac-
cess, it includes a degree of agreement related
to our currently accepted understanding of dis-
tance-interaction processes. Hence, the rules of
evidence are summarized in terms of empirical
findings, the sequence of variables, the strength
of the association, and the consistence with
other studies. It has been suggested that when
an application is effective consistently across a
representative set of indicators, it is not neces-
sary to evaluate all indicators.6 This same no-
tion may apply to the study of access in that
the weight of findings of increased access for a
wide variety of applications in diverse geo-









FIG. 2. Causality in telemedicine.
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reliable evidence of the effects of telemedicine
on access.
Plausibility
With regard to access, this notion is re-
flected in human behavior by the concept of
the distance decay function (Fig. 3). Simply
put, the function describes a decreasing prob-
ability of interaction with a place as the dis-
tance from that place increases. The use of a
distance decay formulation helps identify po-
tential patterns of service utilization by peo-
ple. There is considerable literature, espe-
cially in the mental health field, where it is
known as Jarvis’ Law, that supports this
proposition. Hence, we are on solid ground
in terms of both the Principle of Least Action
and the empirically defined law of distance
interaction function as a basis for implement-
ing telemedicine.
There is a considerable literature to support
the notion that increased distance to medical
care is associated with decreased utiliza-
tion.38–41 Furthermore, other things being
equal, distance can be the determining factor
as to when and if a person takes advantage of
a medical care opportunity.39,42 These empir-
ical observations support the notion of plau-
sibility and directly reflect the basic principles
and laws pertaining to human movement be-
havior.
Coherence
In the telemedicine-access equation, this
means that the increase in accessibility is com-
patible with existing theory and knowledge. It
presupposes a theoretical basis for the assumed
relationship between telemedicine and in-
creased access, which is derived from the ecol-
ogy and ethology of human behavior.
Specificity
Ideally, the effect has only one cause. An out-
come predicted by one primary factor adds
credibility to a causal claim—a single cause is
related to single effect. This would be attained
when we are able to demonstrate that a single
aspect of telemedicine is associated with a sin-
gle effect on access.
Experiment
The demonstration that, under controlled
conditions, changing the exposure causes a
change in the outcome—in this case, the con-
ditions suggested earlier pertaining to the need
for large-scale, clinical trials.
Analogy
Typically, we are more willing to accept ar-
guments that resemble others we have already
accepted. In other words, a commonly accepted
phenomenon in one area can be applied to an-
other area. For telemedicine and access, this
would again refer to the voluminous literature
that supports the notion that placing a medical
facility closer to its target population increases
utilization by that population.
We have proposed here a revised strategy for
evaluating the effects of telemedicine based on
the available and forthcoming evidence, with
special emphasis on the association between
telemedicine and access to care, as an illustra-
tion on the use of this strategy. The impetus for
this effort derives from past, present, and, most
likely, future difficulties encountered in at-
tempting to evaluate the multidimensional and
continually evolving technology and applica-
tions of telemedicine. Moreover, it is important
to note that telemedicine is not the only type of
program that is difficult to evaluate using the
controlled experiment. Suggestions pertainingFIG. 3. Distance decay function.
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to the need for looking toward triangulation as
one means of not only resolving the problem
but also providing more feasible, holistic, and
“surer” analyses are found in other fields as
well. We have argued here that triangulation
may be a viable alternative evaluation strategy
for telemedicine. Additionally, we have pre-
sented a preliminary and, perhaps, rather sim-
plistic first attempt to illustrate the concept and
how it might be implemented. To be sure, ques-
tions pertaining to the operationalization of the
terms and development of appropriate mea-
sures remain to be answered. One central prob-
lem, should the strategy prove viable, is a
mechanism to collect data from various sources
and a central repository for results from the
various types of research methodologies, both
quantitative and qualitative, that will form the
basis for implementing this strategy.
SUMMARY AND CONCLUSION
Despite several decades of growth and de-
ployment of telemedicine programs, a review of
the literature illustrates that, to date, the major-
ity of evaluation studies does not rise to the level
of producing definitive results on the benefits
and costs of this field. Hence, claims of telemed-
icine program efficacy pertaining to improved
access, equal or enhanced quality compared with
traditional medical care, and reduced costs can-
not be made with strong assurance. To review,
reasons for this problem are many, including:
• A failure to use a precise and uniform defi-
nition of “telemedicine,” and the multidi-
mensionality of the innovation bundle of
telemedicine.
• The continuous improvement of the under-
lying technology of telemedicine, and the ex-
pansion of applications.
• Experimental problems, such as:
 Lack of clarity in specifying the experi-
mental variables;
 Difficulty of experimental allocation and
blinding and jumping experimental allo-
cation;
 Limited fidelity in program implementa-
tion, inadequate program maturity, and
steady-state operation;
 Multiplicity of program affects, delayed
effects, and unintended effects; and
 Lack of large-scale programs that would
permit experimental studies.
• Insufficient funding for large-scale experi-
mental studies.
• Failure to exploit the full potential of
telemedicine technologies.
The inadequacies of scientific rigor aside, the
overwhelming majority of published evalua-
tions of telemedicine programs support the no-
tion that telemedicine does improve access. It
is a valid substitute for in-person care in many
applications, and does, or has the potential 
to, reduce opportunity costs. And, in spite of
the lack of substantive evaluation research,
telemedicine programs continue to proliferate,
perhaps not to the extent that proponents feel
is appropriate, given the presumed potential.
Proponents continue to call for support, while
the field is criticized for not having definitive
research evidence to justify its full adoption by
mainstream medicine as an integral component
of the health care armamentarium.
It appears that telemedicine program evalu-
ation is faced with a quandary. Should we con-
tinue to pursue what appears to be a futile
search for definitive results from small, limited
studies that are scientifically rigorous? Or
should we devise a strategy or strategies for as-
sessing all the available evidence in systematic,
coherent, and consistent fashion through trian-
gulation? Should we wait for the credible evi-
dence to emerge or capitalize on existing find-
ings and still pursue the best feasible approach
in such research?
In this paper, we have presented two strate-
gies, which are not mutually exclusive. The first
strategy is to fund large-scale experimental
telemedicine programs and projects that can be
designed and implemented to collect data suf-
ficient to test specific dimensions and effects of
the technology. Data from such studies can
then be assessed with statistical confidence to
draw probable and credible conclusions. We
propose a three-dimensional model for evalu-
ating telemedicine on the basis of the varied
perspectives of the client, provider, and society
at large, the specific clinical or other application,
and the technological configuration. Moreover,
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as findings are reported, results can be accu-
mulated, using this three-dimensional telemed-
icine data matrix, to permit the triangulation of
results and the translation of results into a sum-
mative research format. In turn, the cumulative
research findings would form the basis for
reaching conclusions about the benefits and
costs of telemedicine.
We also propose and illustrated a second al-
ternative using theoretical triangulation as one
basis for assessing the impact of telemedicine on
access to care. This strategy derives from the fact
that in reality our search for the holy grail of sci-
entifically evaluating telemedicine programs in
the traditional manner must be revised. The new
strategy is based on established theory together
with the cumulative data from research studies
that may be based on imperfect designs. The cri-
teria for judging the results include: statistical
significance, temporality, strength, consistency,
coherence, plausibility, analogy, and experi-
ment. We must integrate results from both quan-
titative and qualitative research designs.
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